Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

NCT01633645 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Metastatic

Interventions

DRUG: Bortezomib
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

University Hospital of Crete